Alcon Ag · SIX:ALC
Alcon — Shareholder Meeting (May 2010)
18 slides from Alcon's shareholder meeting presentation, May 21, 2010
Slide 1: Alcon, Inc. Annual General Meeting
Exhibit 99.1 Alcon, Inc. Annual General Meeting May 20, 2010
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation, made on May 20, 2010, includes forward-looking statements based on current expectations and Alcon does not undertake the obligation to update the forward-looking information or statements. These expectations could differ materially from actual results and are
Slide 3: Delivered Solid Operating Performance in 2009
Delivered Solid Operating Performance in 2009 Sales rose 3 3.3% 3% to $6 $6.5 5 billion – Organic growth was 6.3% – Excellent results in challenging market environment Net earnings declined 2.0% to $2.0 billion – Adjusted j net income increased 13.3% – Disciplined actions and spending – Continued to
Slide 4: Investing in and Building for the Future
Investing in and Building for the Future Made significant progress on research capabilities – Expanded and refocused internal resources – Developed rigorous new processes to evaluate and move projects forward Increased access to compounds and technologies – AstraZeneca collaboration provides opportu
Slide 5: Strong Performance in a Challenging Environment
Strong Performance in a Challenging Environment Full Year Global Sales (dollars in millions) +3.3% 3.3% Reported $6,600 +6.3% Organic Growth $6 499 $6,499 $6,400 $6,294 $6,200 $6,000 FY 2008 FY 2009 Organic sales growth is a non-GAAP measure presented to give investors a better comparison of operati
Slide 6: Balanced Global Growth
Balanced Global Growth U.S. / International Sales Growth $8,000 2009 Sales Growth United States Developed International Organic Reported Growth* Emerging Markets $6,000 ons) dollars in millio 44.6% 44.8% +3.8% +3.8% 47.7% $4,000 50.3% 50.3% (d 37.1% 37.3% +3.7% + 6.9% $2,000 36.8% 35.1% 36.2% 18.3%
Slide 7: Diversification Across Therapeutic Areas
Diversification Across Therapeutic Areas Full Year Global Sales by Product Line $4,000 +4.5% Reported +4.0% Reported -3.2% Reported +7.6% 7 6% O Organic i Growth G th +7.1% 7 1% O Organic i Growth G th 0 0% O 0.0% Organic i GGrowth th $3,000 $2,997 ons) $2,881 $2 677 $2,677 dollars in millio $ $2,56
Slide 8: Gross Profit
Gross Profit Full Year (dollars in millions) $5,000 +1.3% 1.3% $4,885 $4,800 $4,822 $4,600 $4,400 FY 2008 FY 2009 % of 76.6% 75.2% Sales
Slide 9: Operating Income
Operating Income Full Year Reported Full Year Adjusted (dollars in millions) (dollars in millions) $2,400 $2,400 +2 2% +2.2% +3 0% +3.0% $2,300 $2,300 $2,280 $2 261 $2,261 $2,200 $2,200 $2,213 $2,213 $2 100 $2,100 $2 100 $2,100 $2,000 $2,000 FY 2008 FY 2009 FY 2008 FY 2009 % of % of 35.2% 34.8% 35.2
Slide 10: Net Earnings
Net Earnings Full Year Reported Full Year Adjusted (dollars in millions, except EPS) (dollars in millions, except EPS) $2,300 $2,300 -2 0% -2.0% +13 3% +13.3% EPS $6.79 EPS $6.81 EPS $6.66 $2,000 $2,047 $2,000 $2,051 , $2,007 EPS $6.00 $1,811 $1,700 $1,700 $1,400 $1,400 FY 2008 FY 2009 FY 2008 FY 20
Slide 11: Steady Cash Flow
Steady Cash Flow Cash Flow from Operations $2,800 $2 416 $2,416 $2,400 millions) $2,032 $2,000 (dollars in m $1,600 $1,406 $1,470 $1,235 $1,200 $ , $800 2005 2006 2007 2008 2009 % Reinvested into Capital 13.1% 15.8% 15.4% 14.9% 14.2% Spending p g
Slide 12: Attractive Dividend Payout
Attractive Dividend Payout Dividend Historical Payout vs. 2010 Proposal $1,200 $1,112 $1 048* $1,048* $1,000 dend ons) $800 $750 ed 2010 Divid (dolllars in millio $613 $600 $417 $400 Propose $302 $200 $169 $107 $ $0 2003 2004 2005 2006 2007 2008 2009 2010 * 2009 dividend includes the impact related
Slide 13: Alcon, Inc. Annual General Meeting
Alcon, Inc. Annual General Meeting May 20, 2010
Slide 14: Non-GAAP Reconciliations
Non-GAAP Reconciliations ALCON, INC. AND SUBSIDIARIES Global Sales (in millions) Twelve Months Ended Foreign December 31, Currency Organic 2009 2008 Change Change Change Sales by Geography: United States $ 2,914 2,807 3.8 % -- 3.8 % Emerging Markets 1,163 1,152 1.0 (10.2) 11.2 Developed Internationa
Slide 15: Non-GAAP Reconciliations
Non-GAAP Reconciliations ALCON, INC. AND SUBSIDIARIES Reconciliation of Non-GAAP Financial Measures (in millions, except share data) Operating Income Full Year Full Year 2009 2009 2008 Growth % As Reported $ 2,261 $ 2,213 2.2% 2009 Reduction in 19 -- -- Force As Adjusted $ 2,280 $ 2,213 3.0 Note: Ad
Slide 16: Non-GAAP Reconciliations
Non-GAAP Reconciliations ALCON, INC. AND SUBSIDIARIES Reconciliation of Non-GAAP Financial Measures (in millions, except share data) Net Earnings Full Year Full Year 2009 2009 2008 Growth % As Reported $ 2,007 2 007 $ 2,047 2 047 (2 0)% (2.0)% 2009 Tax Adjustment 30 -- -- 2009 Reduction in 14 -- --
Slide 17: Non-GAAP Reconciliations
Non-GAAP Reconciliations ALCON, INC. AND SUBSIDIARIES Reconciliation of Non-GAAP Financial Measures (USD in millions) Foreign Currency Organic Change Change Change Advanced Technology IOLs Sales 29.3 % (3.1) 32.4 % Glaucoma Sales 17.4 (3.3) (3 3) 20.7 BRIC Nations Sales 6.0 (10.7) 16.7 Note: Organic
Slide 18: Non-GAAP Reconciliations
Non-GAAP Reconciliations ALCON, INC. AND SUBSIDIARIES Reconciliation of Non-GAAP Financial Measures (in millions) Full Year Full Year 2009 2008 Global Sales $ 6,499 $ 6,294 Net Earnings As $ 2,007 $ 2,047 Reported % of Sales 30 9 30.9 % 32 5 32.5 % Net Earnings As $ 2,051 $ 1,811 Adjusted % of Sales